SBRT2015

Previous Page

Next Page

Page Background

Virtual HDR® Prostate CyberKnife

Radiosurgery: Intermediate

–

term Efficacy

and Toxicity Evaluation

PSA nadir:

% of pts.

< 0.5 ng/ml

1-year

2-year

3-year

38%

59%

100%

PSA

Median (ng/ml)

Range (ng/ml)

(no. at risk)

1-year

2-year

3-year

0.8

(0

–

5.0)

(n = 40)

0.36

(0

–

3.2)

(n = 27)

0.1

(0

–

0.5)

(n =7)

PSA Response: